Literature DB >> 11782101

In vitro cytokine secretion in individuals with schizophrenia: results, confounding factors, and implications for further research.

D Hinze-Selch1, T Pollmächer.   

Abstract

The present paper reviews the results of all publications on in vitro cytokine secretion in patients with schizophrenia, as published by March 2001. The authors supply easy to read tables with respect to the individual cytokines and soluble cytokine receptors investigated, the in vitro methodology used, characterization of the patient samples, and the results on cytokine secretion as stated in these studies. Inconsistent results, e.g., regarding in vitro secretion of IL-2 with 11/18 studies finding decreased secretion, 5/18 finding no change, and 2/18 finding increases, cannot systematically be correlated with any methodological procedures nor any diagnostic subtypes, per se. However, factors such as medication and cigarette smoking are likely to play a role. The authors suggest that more hypothesis-driven research, together with more carefully designed studies, as well as better communication between basic or animal researchers and clinicians might help to answer the question of whether there are meaningful peripheral changes in the immune system related to schizophrenia. Copyright 2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11782101     DOI: 10.1006/brbi.2001.0645

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  10 in total

Review 1.  The stress-vulnerability hypothesis in psychotic disorders: focus on the stress response systems.

Authors:  Christine C Gispen-de Wied; Lucres M C Jansen
Journal:  Curr Psychiatry Rep       Date:  2002-06       Impact factor: 5.285

2.  Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia.

Authors:  Tsuyoshi Miyakawa; Lorene M Leiter; David J Gerber; Raul R Gainetdinov; Tatyana D Sotnikova; Hongkui Zeng; Marc G Caron; Susumu Tonegawa
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-08       Impact factor: 11.205

3.  A controlled prospective study of toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence.

Authors:  Dunja Hinze-Selch; Walter Däubener; Lena Eggert; Sükran Erdag; Renate Stoltenberg; Sibylle Wilms
Journal:  Schizophr Bull       Date:  2007-03-26       Impact factor: 9.306

Review 4.  Immunological aetiology of major psychiatric disorders: evidence and therapeutic implications.

Authors:  Barbara Sperner-Unterweger
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Effects of cytokines and infections on brain neurochemistry.

Authors:  Adrian J Dunn
Journal:  Clin Neurosci Res       Date:  2006-08

6.  Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.

Authors:  V Saviouk; E W C Chow; A S Bassett; L M Brzustowicz
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

Review 7.  [Cytokine network in patients with schizophrenia and its significance for the pathophysiology of the illness].

Authors:  A Schuld; D Hinze-Selch; Th Pollmächer
Journal:  Nervenarzt       Date:  2004-03       Impact factor: 1.214

8.  Targeting the Immune System with Pharmacotherapy in Schizophrenia.

Authors:  Jennifer K Melbourne; Benjamin Feiner; Cherise Rosen; Rajiv P Sharma
Journal:  Curr Treat Options Psychiatry       Date:  2017-04-18

9.  Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder.

Authors:  N Konuk; I O Tekin; U Ozturk; L Atik; N Atasoy; S Bektas; A Erdogan
Journal:  Mediators Inflamm       Date:  2007-02-27       Impact factor: 4.711

Review 10.  The neuroimmunology of schizophrenia.

Authors:  Annya M Smyth; Stephen M Lawrie
Journal:  Clin Psychopharmacol Neurosci       Date:  2013-12-24       Impact factor: 2.582

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.